Author: Biotech Metropolitan Women

With its flagship site at the Alexandria Center for Life Science – New York City, Alexandria LaunchLabs provides move-in-ready office/laboratory space, first-class support resources, shared equipment and services, creative amenities, and access to startup capital through the Alexandria Seed Capital Platform. Located within Manhattan’s East Side Medical Corridor, the Alexandria Center for Life Science is home to a diverse range of high-quality life science entities, from multinational pharmaceutical companies to early- and growth-stage companies. The campus offers Alexandria LaunchLabs’ tenants a unique environment to continue to grow and to accelerate innovation.

Dr. Lindsay Rosenwald of Fortress Biotech Fortress Biotech Or, if you prefer, collecting muffin tops. “Some people won’t eat the tops of muffins,” Rosenwald explained. “That’s what we’re looking for — is muffin tops. Our lab is the entire world and all the research done in the world. That’s a large number. The calculation I made is around $200 billion is spent in the United States and all over the world in life science research and development annually.” The “muffin tops” Rosenwald is referring to are drugs being developed by major pharmaceutical companies and startups alike, which will never make…

Health-care investment firm Deerfield Management Co. is moving to convert a Manhattan building into a drug-research laboratory and office space for $635 million, a promising sign that long-running efforts to turn New York City into a hub for the biotech industry are taking root. New York-based Deerfield recently bought […] Click here to view original web page at www.wsj.com

NEW YORK–( BUSINESS WIRE )– Schrödinger today announced the appointment of Nancy Thornberry, a biotech executive recognized for her extensive track record in drug discovery and development, to its Board of Directors. Ms. Thornberry, the Chief Executive Officer of Kallyope Inc., brings over 30 years of biopharma leadership to […] Click here to view original web page at www.businesswire.com

Crain’s New York Business published their 2019 list of Most Powerful Women in New York this past June. The list recognizes 50 prominent business and civic leaders that have made a positive impact on the city’s culture and economic growth to date. In celebration of that list, Crain’s hosted a luncheon on Tuesday complete with an honoree panel discussion to an audience of over 600 professional and diverse women (and men) at Cipriani’s midtown landmark venue. The event also provided gracious networking opportunities with distinguished professionals across all sectors. Moderated by Associate Editor of Crain’s New York Business, Christin Dare-Bryan,…

Goodwin Welcomes Life Sciences Licensing and Collaboration Partner Lily Wound in New York September 12, 2019 11:18 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Global law firm Goodwin announced today that Lily Wound has joined its Technology and Life Sciences practices as a partner in the New York office. Wound represents emerging and mid-sized pharmaceutical, biotechnology and other life sciences companies on a wide range of complex commercial, corporate and licensing transactions, including in fields such as gene therapy, gene editing, engineered cell therapy and genomic testing. With broad knowledge of licensing and collaboration matters, she handles transactions at every stage…

Robert Wasserman, MD, joins Rgenix with more than 20 years of oncology clinical development experience and prior senior roles in the biopharma industry. Wasserman will oversee new Phase 1b/2 trial of lead compound RGX-104 in lung cancer patients; and RGX-202 Phase 1b/2 trial in patients with colorectal and gastric cancer September 16, 2019 09:30 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Rgenix, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced today that Robert Wasserman, MD, has joined the Rgenix management team as its new Chief Medical Officer. Dr. Wasserman takes on his new role…

September 12, 2019 08:30 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Medidata (NASDAQ: MDSO) and Mapi Research Trust today announced a new critical mission: to build a digital, global library of pre-configured and pre-approved eCOA (clinical outcomes assessment) questionnaires. The collaboration will create reusable versions of MRT distributed questionnaires in Medidata Rave eCOA, collecting COA data from hundreds of studies each year on the Medidata platform. “This new collaboration with MRT will seek to solve two major eCOA implementation struggles that affect the pharmaceutical industry – the rework involved in building the same questionnaire in multiple studies for different sponsors, and…

Although Boston and California may be more internationally renowned as biotech hubs, New York is fast catching up. Thanks in large part to its strong scientific and business infrastructure and easy access to capital, growing numbers of early-stage biotechs are choosing to base their operations in New York and […] Click here to view original web page at pharmaboardroom.com

September 04, 2019 08:00 AM Eastern Daylight Time SAN FRANCISCO & NEW YORK & VANCOUVER, British Columbia & BASEL, Switzerland–(BUSINESS WIRE)–Since it was conceived, Versant Ventures has provided enabling support for the design and launch of an independent new venture capital and growth equity investment firm dedicated to the medtech sector. Today Vensana Capital debuted with the closing of its inaugural fund, Vensana Capital I, with $225 million in committed capital. The fund was oversubscribed, and it was raised from a broad range of institutional investors including public pensions, university endowments, foundations, leading academic health systems, family offices and fund-of-funds.…

MORRISTOWN, N.J., Sept. 03, 2019 (GLOBE NEWSWIRE) — Melinta Therapeutics, Inc. (Nasdaq: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial infections, today announced that Jennifer Sanfilippo has been named interim chief executive officer and director, effective August 28, 2019. Prior […] Click here to view original web page at www.globenewswire.com

Harlem Biospace- Columbia Entrepreneurship Harlem Biospace is open to life-science companies and technology companies using biological techniques

The LifeSci NYC Growth Fund New York City’s life sciences ecosystem offers opportunities across three key areas: funding, space and talent.

Responsible Investing (RI) has increasingly become a rule for today’s socially conscience capitalists that want to implement their value set into portfolio construction. Women, who now account for 51% of investable wealth, and millennials, are proving to traditional investment houses that their money has power. These investors deem it necessary to consider the ethical impact of businesses and companies in their evaluation of investment opportunities. Biotech Metropolitan Women should understand where we fit into this movement and identity our allies in funding to support the inception and growth of our biotech enterprises. I recently attended a seminar in Connecticut with…

Implied total company value of up to USD 1 billion, inclusive of 40.8 percent stake currently held by Bayer / Initial focus in neurology, cardiology, and immunology with start of first clinical program in Parkinson’s disease expected later this year / BlueRock Therapeutics to continue to operate as an independent company Berlin/Cambridge, Massachusetts, August 8, 2019 – Bayer AG and BlueRock Therapeutics today announced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology company focused on developing engineered cell therapies in the fields of neurology, cardiology and immunology, using a proprietary induced pluripotent stem…

Bio & Health Tech Entrepreneurship Lab NYC Scientists and engineers, doctors and business students who are working with technology based innovations that inspire entrepreneurship can find themselves seeking business skills and networks to help navigate the challenges of commercialization. ELabNYC, teaches business skills and networks participants to start up resources. In teaching, we prepare our program participants for the startup world to confidently persevere through the continued challenges they will face. In networking, we introduce participants to experts nationwide to navigate business issues in the technical and complex world of life science business.

Joe Wojcik © 2020 American City Business Journals. All rights reserved. Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement (updated 1/1/20) and Privacy Policy and Cookie Statement (updated 1/1/20). The material on this site may not be reproduced, distributed, transmitted, cached […] Click here to view original web page at www.bizjournals.com

Click here to view original web page at www.nasdaq.com TARRYTOWN, N.Y., July 18, 2019 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced the winners of the seventh annual Regeneron Prize for Creative Innovation. The country’s leading research universities were asked to nominate top candidates for the Regeneron Prize in the ‘graduate student’ and ‘postdoctoral fellow’ categories. In total […]

1. Celmatix14 Wall Street, Suite 16DNew York, NY 10005. Focus on a female’s infertility and women’s health through technology-enabled products and better data.2. Harlem Biospace 423 W 127th StreetNew York, NY 10027 Harlem Biospace is a biotech incubator, the first of its kind in New York City that offers a affordable shared wet-lab space for competitively-selected entrants.3. TARA Biosystems 430 E 29th StNew York, NY 10016 Pioneers predictive tissue models that enable development of new medicines for cardiac physiology, as well as can help reduce and potentially eliminate, the use of animals in drug development.4. Iovance Biotherapeutics 112 W. 34th…

We are in the course of Metropolitan New York executing its plan to become a major hub for biotechnology. We certainly have the appropriate lattice of talent- major medical research institutions in the hotbed of Pharm Country with direct subway lines to venture capital. The city is excited about the magnitude of unleashed potential finally receiving the level of support required to become a global leader in R&D and innovation in the life sciences. This initiative is propelling life sci start-ups as entrepreneurs take advantage of New York City’s ten point plan. The strategy includes 300 million in tax incentives…

Posted on November 30, 2018 Author Comments Off on NY Biotech Leaders Pursue Empire State of Mind with One-Stop Shop Proposal Alex Philippidis Senior News Editor Genetic Engineering & Biotechnology News Think tank is also promoting tax credit extensions, tailored incentives, and easier tech transfer as cures for state’s life science blues. For years New York state has had the makings of a strong biotechnology cluster. It graduates the nation’s fourth-highest number of bioscience majors (9,630 in the 2008 academic year). Its academic institutions spend some $2.7 billion on bio R&D, more than any state except California. New York is…

NEW YORK, May 15, 2019 /PRNewswire/ — Oppenheimer & Co. Inc. (“Oppenheimer”) – a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY ) – will host its New York Oncology Insight Summit at The Barclay Intercontinental Hotel in New York City on May 16, […] Click here to view original web page at www.prnewswire.com

NEW YORK, May 15, 2019 /PRNewswire/ — Oppenheimer & Co. Inc. (“Oppenheimer”) – a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY ) – will host its New York Oncology Insight Summit at The Barclay Intercontinental Hotel in New York City on May 16, […] Click here to view original web page at www.prnewswire.com

The emerging biotech scene in New York is refreshingly akin to the city’s eclectic metropolitan culture. The city’s liberal and progressive landscape yields a diverse talent pool with the necessary attributes to spearhead medical science advancement. Compared to other biotech hubs (eg. Biotech Bay, Biotech Beach, Biotech Capital), the opportunity might different for the women founding innovative start-ups in metropolitan New York. This city possess a sophisticated ingenious archetype that “make it happen”. For all of the tri-state’s powerful women possessing the expertise, tenure and inclination to run life-sci companies and sit at executive boards, it is ever critical to…

A breast cancer cell. biotech based on the frightening fact that some cancer cells spread throughout the body even before a tumor is detectable emerged from stealth mode on Thursday, announcing it had raised roughly $60 million from, among others, early-stage venture capital companies and one of biotech’s 800-pound […] Click here to view original web page at www.statnews.com